Financials
- Market Capitalization 122.16 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 241 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 659.61 USD | -0.74% | +1.49% | +8.33% | +16.52% | 69.15 B USD | ||
| 294 | ARGX argenx SE - American Depositary Shares | 871.80 USD | -0.66% | -6.02% | -3.13% | +56.02% | 53.95 B USD | ||
| 382 | RVMD Revolution Medicines, Inc. - Common Stock | 181.70 USD | -2.77% | -4.07% | +18.73% | +227.98% | 38.63 B USD | ||
| 386 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 286.24 USD | -4.19% | -9.06% | -0.94% | -9.11% | 38.22 B USD |
Frequently asked questions about Vertex Pharmaceuticals Incorporated - Common Stock
What is the Vertex Pharmaceuticals Incorporated - Common Stock stock price today?
The current price of Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) is 481.31. Over the past 24 hours, the stock has changed by -0.84%. Follow the VRTX chart for real-time price dynamics.
What is the stock ticker of Vertex Pharmaceuticals Incorporated - Common Stock?
Vertex Pharmaceuticals Incorporated - Common Stock trades under the ticker VRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vertex Pharmaceuticals Incorporated - Common Stock stock going up?
VRTX has changed by -9.09% over the last week, +9.38% over the last month, and +3.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Vertex Pharmaceuticals Incorporated - Common Stock net income for the last quarter?
Vertex Pharmaceuticals Incorporated - Common Stock reported net income of 1.03 B for the last quarter. The previous quarter showed 1.19 B, which means net income changed by -13.41%.
How many employees does Vertex Pharmaceuticals Incorporated - Common Stock have?
As of the latest available data, Vertex Pharmaceuticals Incorporated - Common Stock has 6 400 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vertex Pharmaceuticals Incorporated - Common Stock EBITDA?
Vertex Pharmaceuticals Incorporated - Common Stock EBITDA is 1.19 B, and its EBITDA margin is 39.97%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vertex Pharmaceuticals Incorporated - Common Stock stock?
You can buy Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vertex Pharmaceuticals Incorporated - Common Stock stock?
Investing in Vertex Pharmaceuticals Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRTX chart and related analysis on metatrader.com as part of your research.